PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate Cancer
Haixia He,Qianghua Zhou,Yangjie Zhang,Yi Li,Lin Ding,Ting Shen,Sen Liu,Shengmeng Peng,Ming Huang,Hua Zhou,Liang Cheng,Ruihui Xie,Qiang Zhang,Junlin Lu,Liting Li,Jing Yang,Shoumin Bai,Tianxin Lin,Xu Chen
DOI: https://doi.org/10.1002/advs.202405997
IF: 15.1
2024-09-19
Advanced Science
Abstract:PTBP1 is overexpressed in prostate cancer and is associated with poor prognosis. PTBP1 markedly reinforced genomic DNA stability to desensitize prostate cancer cells to irradiation. Mechanistically, PTBP1 binds to RALY and together regulates alternative splicing of DNMT3B to increase DNMT3B‐L accumulation, leading to hypermethylation of the DUSP2 promoter and downregulation of its expression, and then increasing radioresistance of prostate cancer. Radiotherapy is a curative arsenal for prostate cancer (PCa), but radioresistance seriously compromises its effectiveness. Dysregulated RNA splicing factors are extensively involved in tumor progression. Nonetheless, the role of splicing factors in radioresistance remains largely unexplored in PCa. Here, 23 splicing factors that are differentially expressed between PCa and adjacent normal tissues across multiple public PCa databases are identified. Among those genes, polypyrimidine tract binding protein 1 (PTBP1) is significantly upregulated in PCa and is positively associated with advanced clinicopathological features and poor prognosis. Gain‐ and loss‐of‐function experiments demonstrate that PTBP1 markedly reinforces genomic DNA stability to desensitize PCa cells to irradiation in vitro and in vivo. Mechanistically, PTBP1 interacts with the heterogeneous nuclear ribonucleoproteins (hnRNP) associated with lethal yellow protein homolog (RALY) and regulates exon 5 splicing of DNA methyltransferase 3b (DNMT3B) from DNMT3B‐S to DNMT3B‐L. Furthermore, upregulation of DNMT3B‐L induces promoter methylation of dual‐specificity phosphatase‐2 (DUSP2) and subsequently inhibits DUSP2 expression, thereby increasing radioresistance in PCa. The findings highlight the role of splicing factors in inducing aberrant splicing events in response to radiotherapy and the potential role of PTBP1 and DNMT3B‐L in reversing radioresistance in PCa.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry